Back to Search
Start Over
Pulmonary 3 He Magnetic Resonance Imaging Biomarkers of Regional Airspace Enlargement in Alpha-1 Antitrypsin Deficiency.
- Source :
-
Academic radiology [Acad Radiol] 2017 Nov; Vol. 24 (11), pp. 1402-1411. Date of Electronic Publication: 2017 Jun 20. - Publication Year :
- 2017
-
Abstract
- Rationale and Objectives: Thoracic x-ray computed tomography (CT) and hyperpolarized <superscript>3</superscript> He magnetic resonance imaging (MRI) provide quantitative measurements of airspace enlargement in patients with emphysema. For patients with panlobular emphysema due to alpha-1 antitrypsin deficiency (AATD), sensitive biomarkers of disease progression and response to therapy have been difficult to develop and exploit, especially those biomarkers that correlate with outcomes like quality of life. Here, our objective was to generate and compare CT and diffusion-weighted inhaled-gas MRI measurements of emphysema including apparent diffusion coefficient (ADC) and MRI-derived mean linear intercept (L <subscript>m</subscript> ) in patients with AATD, chronic obstructive pulmonary disease (COPD) ex-smokers, and elderly never-smokers.<br />Materials and Methods: We enrolled patients with AATD (n = 8; 57 ± 7 years), ex-smokers with COPD (n = 8; 77 ± 6 years), and a control group of never-smokers (n = 5; 64 ± 2 years) who underwent thoracic CT, MRI, spirometry, plethysmography, the St. George's Respiratory Questionnaire, and the 6-minute walk test during a single 2-hour visit. MRI-derived ADC, L <subscript>m</subscript> , surface-to-volume ratio, and ventilation defect percent were generated for the apical, basal, and whole lung as was CT lung area ≤-950 Hounsfield units (RA <subscript>950</subscript> ), low attenuating clusters, and airway count.<br />Results: In patients with AATD, there was a significantly different MRI-derived ADC (P = .03), L <subscript>m</subscript> (P < .0001), and surface-to-volume ratio (P < .0001), but not diffusing capacity of carbon monoxide, residual volume or total lung capacity, or CT RA <subscript>950</subscript> (P > .05) compared to COPD ex-smokers with a significantly different St. George's Respiratory Questionnaire.<br />Conclusions: In this proof-of-concept demonstration, we evaluated CT and MRI lung emphysema measurements and observed significantly worse MRI biomarkers of emphysema in patients with AATD compared to patients with COPD, although CT RA <subscript>950</subscript> and diffusing capacity of carbon monoxide were not significantly different, underscoring the sensitivity of MRI measurements of AATD emphysema.<br /> (Copyright © 2017 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Aged
Aged, 80 and over
Biomarkers
Female
Helium
Humans
Isotopes
Male
Middle Aged
Proof of Concept Study
Pulmonary Diffusing Capacity
Pulmonary Disease, Chronic Obstructive diagnostic imaging
Pulmonary Disease, Chronic Obstructive physiopathology
Pulmonary Emphysema etiology
Quality of Life
Radiopharmaceuticals
Residual Volume
Smoking Cessation
Total Lung Capacity
Diffusion Magnetic Resonance Imaging methods
Magnetic Resonance Imaging methods
Pulmonary Emphysema diagnostic imaging
Pulmonary Emphysema physiopathology
Tomography, X-Ray Computed
alpha 1-Antitrypsin Deficiency complications
Subjects
Details
- Language :
- English
- ISSN :
- 1878-4046
- Volume :
- 24
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Academic radiology
- Publication Type :
- Academic Journal
- Accession number :
- 28645458
- Full Text :
- https://doi.org/10.1016/j.acra.2017.05.008